Source link : https://www.newshealth.biz/health-news/intranasal-insulin-drug-combo-promising-for-alzheimers/
The combination of intranasal insulin (INI) and the sodium-glucose cotransporter 2 inhibitor (SGLT2i) empagliflozin had positive effects on cognition and immune and inflammatory biomarkers in patients with mild cognitive impairment (MCI) or early Alzheimer’s disease (AD), in a phase 2 trial. “We saw encouraging preliminary effects on cognition and white matter integrity for insulin and […]
Author : News Health
Publish date : 2024-11-06 07:18:08
Copyright for syndicated content belongs to the linked Source.
inHealth